News
Complete Response Letters recently issued by the FDA signal heightened scrutiny of trial design and reinforce the agency’s shifting regulatory expectations for sponsors and CROs.
Objective Radiotherapy (RT) can cause a range of negative impacts in addition to the intended treatment impacts. Pulmonary rehabilitation (PR) may improve the physical and psychological conditions of ...
New statistical frameworks such as net treatment benefit offer a multidimensional approach to evaluating efficacy, safety, ...
Study design: only randomised controlled trials will be included in the study ... Figure 1 shows the PRISMA flow diagram of the literature selection in this study. Actual screening numbers will be ...
Combining insulin treatment with the investigational drug dapagliflozin may improve health outcomes for adolescents with type ...
BACKGROUND: Whether cannabis is a risk factor for cardiovascular events is unknown. We examined the association between smoking cannabis and cardiovascular events in a cohort of older veterans (66 to ...
Worried about looming tariffs on tech? Our experts review more than 1,500 products each year. Our mega-guide, updated monthly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results